Pharm Flashcards
SSRI
AE (early and late)
Ex: Fluoxetine, paroxetine, sertraline, escitalopram, citalopram, fluvoxamine
Early AE: Nausea, anxiety, insomnia - will go away
Late AE: decreased all 3 sexual responses (libido, sexual arousal, and orgasm) - wont go away
Use with alcohol can cause depression
Safe for breastfeeding moms
1st line in children and adolescents however there is a “black box warning” for increased risk of suicidal thinking and behavior, so started on low dose.
Continue to 6 months after remission of depressive symptoms
SNRI
AE
Ex: Venlafaxine, Duloxetine, Desvenlafaxine
AE:
- Itching or rash
- Increased BP or HR
Bupropion
MOA, Use, AE
MOA: Norepinephrine & dopamine reuptake inhibitor
Use: Used for depression, smoking cessation.
AE: increase sz threshold for anorexic/bulimic patients. Favorable sexual side effect
Indomethacin
MAO, Use, AE
NSAID
Use:
1. Tocolytic used at <32 weeks, poses greater risk of used >32 weeks
2. 1st line for gout
AE: Chronic renal disease, GI bleed
Alternative medicine
Saw Palmetto: Benign prostatic hyperplasia
Garlic: Hypercholesterolemia
St. John’s wort: Depression
Glucosamine & Chondroitin: Osteoarthritis
Ginkgo biloba: used as a memory booster. AE: increased risk of bleeding and plt dysfunction (#1), seizures, HA, irritability, restlessness, D/N/V
ADAPT
what is is, tx
Cause: most commonly 1st gen antipsychotic
Acute dystonia: sustained muscular contraction –> Benztropine, Diphenhydramine
Akathesia: restlessness, pacing, tapping –> Benztropine, Benzo, Beta blocker
Parkinsonism: rigidity, mask facies, shuffling gait, tremor –> Benzotropine, Amantadine
Tardive dyskinesia: lip-tongue smacking, repetitive/uncontrolled –> stop med, switch to 2nd gen antipsychotic (Clozapine), Valbenazine
Steroids
AE for skin, Endocrine, Eyes, Neuro, Immune, GI, Cardio
- Skin: Atrophy, easy bruising
- Endocrine: adrenal insufficiency, hyperglycemia, linear growth impairment, osteoporosis
- Eyes: cataracts
- Neuro: behavior and sleep disturbances
- Immune: Neutrophilia, immuosuppresssion
- GI: Gastrisitis, ulcers, GI bleed
- Cardio:HTN
Inhaled steroids
AE and its Tx
AE: oral candidiasis (thrush) which can be removed, showing areas of inflammation.
Comp: esophagitis
Tx: Topical antifungal (nystatin suspension or clotrimazole). Resistant form can be treated with oral fluconazole.
HTN Meds
AE of Loops, Thiazide, ACE, ARB
How to stop if possible
Loops
AE: OHHH DANG - Ototoxicity, HypoK, HypoH+ HypoMg, Dehydration, Sulfa allergies, Nephritis, Gout
Thiazides
AE: HyperGLUC (glucose, lipids, uric acid, calcium) and Hypo Na, K, H+, Pancreatitis, Sulfa allergies
Although it causes hypercalcemia, doesn’t cause constipation
ACEs:
AE: CATCHH - cough, angioedema, teratogen, high creatinine (decrease GFR), HyperK, Hypotension, and Pancreatitis
ARB’s:
AE: caTCHH: teratogen, high creatinine (decrease GRF), hyperK and hypotension and Pancreatitis
Can stop if stable BP below target BP for at least a year with good adherence to nonpharmacologic measures. Discontinue 1 medication at a time. Can decrease dose daily or take every other day over 1-2 months. Abrupt discontinuation of a short-acting drug can cause rebound hypertension.
Doxycycline
Use, AE
Lymes, Rocky Mountain, acne vulgaris
AE: photosensitivity, Effect bone and teeth in kids
Isotretinoin
4 AE
Nodulocystic acne may initially flare up and subsequently improve within the first few weeks of isotretinoin therapy.
Teratogenicity: 2 negative pregnancy test beforehand, 2 concurrent methods of contraception (1 month before, during and month after)
Other AE: dry skin & mucous membranes, myalgias, pseudotumor cerebri (with other tetracycline used)
OCP
MOA
Combined hormone contraception –> constant elevated systemic levels of estrogen and progesterone –> negative feedback of hypothalamus (decrease pulsatile release) and anterior pituitary (decrease LH, FSH)
Doxorubicin (AE)
Trastuzumab (AE)
AE: Cardiotoxicity (strongly related to cumulative doses and is irreversible)
Monitor with Radionuclide ventriculography: quantitating LVEF.
Performed at baseline before chemotherapy and before each subsequent dose of chemotherapy.
Regimen is dependent on baseline cardiac function…CI if EF <30%.
Decrease in EF by >10% warrants discontinuation of therapy.
________________________________________________
Trastuzumab
Monoclonal antibody against HER-2
AE:
- Decline in LVEF –> HF. This cardiotoxicity is reversible and there is complete recovery after treatment discontinuation.
Methotrexate
AE
AE: inhibits DHFR which is needed to convert folic acid into folinic acid –> folate deficiency –> macrocytic anemia
Tx: Folinic acid (Leucovorin)
TCA
Toxicity Sx , Tx
Ex: Amitriptyline, Nortriptyline
CNS: AMS, Seizures, Respiratory depression
Cardio: Sinus Tachy, hypotension, Prolonged PR/QRS/QT interval, Arrhythmia
Anti-cholinergic: Dry mouth, dry skin (inhibits diaphoresis) blurry vision, dilated pupils, urinary retention, flushing, hyperthermia, constipation
Tx: Oxygen, Intubation, IVF, Activated charcoal (if within 2 hrs), IVF sodium bicarbonate for QRS interval widening or ventricular arrhythmia (blocks fast Na channels and neutralized TCA
Fentanyl
MOA, AE
MOA: Short-acting opioid analgesic
AE: Respiratory depression, Exacerbated hypotension
Ketamine
MOA, AE
MOA: NMDA receptor antagonist/phencyclidine derivative
Preferred med for awake intubation of difficult airways. Provided dissociation, amnesia, and analgesia
AE: hypertension
Propofol
MOA: GABA receptor agonist
Rapid onset sedation and amnesia
AE: Respiratory depression, hypotension, loss of airway reflex
Rocuronium
Succinylcholine
MOA, AE
Neuromuscular blocking agents used for sedation.
Both cause paralysis, loss of upper airway tone, cessation of all respiratory efforts
Parkinsonism drugs
Levodopa (MOA)
Amantadine (MOA, Toxicity)
Pramipexol (MOA, toxicity)
Levodopa
MOA:
- dopamine immediate precursor
- Can cross BBB and be converted to dopamine.
- Rapidly metabolizes peripherally to dopamine and 3-O-metyldopa.
- Excess peripheral dopamine –> N/V, tachyarrhythmia, postural hypotension
- Carbidopa blocks peripheral conversion and increases amount of dopamine going to the brain. This decreases peripheral AE but not central AE.
_______________________________________________AAmantadine: - Increases dopamine release and decreases dopamine reuptake
Toxicity = Psychosis, ataxia, livedo reticularis.
_______________________________________________
Pramipexole - Dopamine agonist
Toxicity: impulse control disorder (eg,
gambling), postural hypotension, hallucinations/confusion.
Metformin
- Decrease hepatic glucose production
- Decrease intestinal glucose absorption
- Increase peripheral glucose uptake/utilization
- Decrease Lipogenesis
AE: Diarrhea, lactic acidosis, Vit B12 deficiency
Amiodarone
AE
MOA: K channel blocker
- Pulmonary toxicity (responsible for most deaths). Tx - discontinuation
- Photosensitivity
- Blue-grey skin discoloration
- Bone marrow suppression
- Abnormal liver function test
- Thyroid dysfunction:
—Hypo: inhibits conversation of T4 to T3
—Hyper: increase thyroid hormone synthesis or release of preformed thyroid hormones.
SERM
Names, MOA, AE
Tamoxifen and Raloxifene
MOA: competitive inhibitor of estrogen binding
Mixed agonist/antagonist action
Tamoxifen: adjuvant tx for breast cancer
Raloxifene: postmenopausal osteoporosis
AE:
Both: Hot flashes, Venous thromboembolism, Tamoxifen: Endometrial hyperplasia & carcinoma and uterine sarcoma
— Regular screening is not proven beneficial, so only evaluate if sx develop.
Rituximab
MOA
IgG monoclonal antibody against CD20 (a surface molecule presenting on developing and mature B-cells).
This binding on CD20 –> Fc receptor – mediated B-cell cytotoxicity & antibody-dependent B-cell phagocytosis, which significantly reduces B cell population.
Reduced B cells –> reduced inflammation